EXTERNAL COLLABORATORS
Professor Zoltan Molnar
Professor of Developmental Neuroscience at the University of Oxford
Distribution of T14 in the brain developing and adult rodents with microscopy.
Professor Robin Murphy
Professor of experimental psychology at the University of Oxford
A novel animal model of Alzheimer’s disease.
Professor Angela Russell
Professor of Medicinal Chemistry at the University of Oxford
Design of next generation therapeutics for Alzheimer’s disease
Dr Pol Hernandez Lladó
Postdoctoral Research Associate in Medicinal Chemistry at the University of Oxford
Design of next generation therapeutics for Alzheimer’s disease
Dr Felicia Green
Associate Investigator, Postdoctoral Research Associate in Mass Spectrometric Instrumentation at the Rosalind Franklyn Institute
Identification of T14 in fluids using Mass spectrometry
Dr Daniel McGill
Postdoctoral Research Associate in molecular structure elucidation at the Rosalind Franklyn Institute
Identification of T14 in fluids using Mass spectrometry.
Dr Neus Falgas
Neurologist at the Hospital Clinic de Barcelona
Development of a biomarker for Alzheimer’s disease
Professor Tobias Bast
Associate Professor at University of Nottingham.
Novel animal model of Alzheimer’s (T30).
Professor Mark Collis
Deputy Director of the Mass Spectrometry Centre at University of Sheffield.
Detection of T14 in blood/brain/CSF using Mass Spectrometry.
Professor Isabel Bermúdez-Diaz
Professor of Neuropharmacology at Oxford Brookes University.
Target engagement: characterisation of the binding of the peptide and drugs on the alpha7 nicotinic receptor.
Dr Steven Cobb
Associate Professor in Chemical-Biology and Director of the Centre for Global Infectious Diseases at Durham University.
Drug discovery: peptoid and peptide chemistry to tackle interesting and challenging biological problems. He is a valued member of our Drug Risk Task Force.
Professor María-Salud García Ayllón
Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with pathology
Dr Gregory Cole
Professor of Medicine and Neurology at University of California, Los Angeles
Alzheimer’s: Proof of concept and characterisation of NBP14 in pathology
Professor Javier Saez-Valero
Principal Investigator at Universidad Miguel Hernández de Elche
Proof of concept: Comparison of rat embryo brains with AD pathology.
Dr Nadine Kabbani
Associate Professor at the School of Systems Biology of the George Mason University.
Calcium signalling via the alpha 7 type nicotinic receptor and influence on the synaptic development in the brain.
Professor Robin Anderson
Head of the Translational Breast Cancer Program and the Metastasis Research Laboratory at the Olivia Newton-John Insitute.
Genetic regulation of metastasis, primarily in breast cancer, and identification of new targets for molecular based therapy for patients with progressive disease.
Professor Andis Klegeris
Professor of Biology at the University of British Columbia.
Pharmacology; neuroimmunology; inflammation and neurodegenerative diseases.
Dr Raquel Boque-Sastre
Head of the project Therapeutic approach to colorectal cancer at Xenopat
Professor Philipa Saunders
Chair of Reproductive Steroids at the University of Edinburgh
Professor Andrew W Horne
Professor of Gynaecology and Reproductive Sciences at the University of Edinburgh
Professor Lea Grinberg
Professor in Neurology at UCSF
Understanding the localization of T14 in the brain.
Professor Lorna Harries
Professor of Molecular Genetics & Founder and CSO of SENISCA
To explore the correlation between T14 and AChE-R mRNA
Dr James Murray
Senior Lecturer in Autophagy and Ageing Diseases at Swansea University
How T14 influences longevity
Jean-Phillippe Courtois
Unilever: Prestige Senior Open Innovation Manager
Gianpaolo Zerbini
Research Associate, Complication of Diabetes
T14 studies in the retina
Dr Claire Sheppard
Dr Claire Shepherd is the Director of the Sydney Brain Bank at Neuroscience Research Australia
